6505-01-550-0877

Find complete technical information, availability, and procurement data for: 6505-01-550-0877
DODParts.com distributes related products varnishes dopes paints, aircraft parts and consumables, electrical parts, fittings and other components for the aerospace and defense industries. Submit the short price quote form for NSN 6505-01-550-0877 to receive an up to date pricing and availability quote by email.

Federal Supply Group

Medical, Dental, and Veterinary Equipment and Supplies

Federal Supply Classification

6505 Drugs and Biologicals

National Stock Number

6505-01-550-0877

Item Name Code

66554

Assigment Date

04/09/2007 (19 years ago)

An item designed to couple or join two different types or sizes of conduits, and/or to be inserted in the opening of a conduit outlet or box to accommodate a conduit of a larger or smaller size; or it may be designed with internal thread on one end for mating with an electrical connector and an external thread on the other end for mating with a conduit coupling nut; or to establish necessary mechanical accommodations between an electrical conduit, conduit assembly and an electrical connector. Excludes:reducing washer, knockout and box connector, electrical. See also adapter, cable to connector; and chase nipple, conduit.

benzocaine ,10% (zilactin-b) gel 7 gram tube for painful sores inside of mouth. lasts up to 6 hours. store at 20 to 25 c (68 to 77 f); excursions per mitted from 15 to 30 c(59 to 86 f)(see usp controlled room temperature) flammable, keep away from fire or flame. special features, benzocaine 10% zilactin-b gel 7 gram tube part name assigned by controlling agency, 10.000 percentage, w/v benzocaine active ingredient active medicament medicinal strength, tube primary container type, 7.500 grams primary container content quantity

Product Characteristics

Below you’ll find the complete technical specifications and performance data for this part, including material details and compliance information.

Active Medicament Medicinal Strength: 10.000 percentage, w/v benzocaine active ingredient
Primary Container Type: tube
Primary Container Content Quantity: 7.500 grams
Part Name Assigned By Controlling Agency: benzocaine 10% zilactin-b gel 7 gram tube
Special Features: benzocaine ,10% (zilactin-b) gel 7 gram tube for painful sores inside of mouth. lasts up to 6 hours. store at 20 to 25 c (68 to 77 f); excursions per mitted from 15 to 30 c(59 to 86 f)(see usp controlled room temperature) flammable, keep away from fire or flame.
Medical Designation And Grade: united states pharmacopeia

Related Parts

This NSN group includes multiple components designed to meet specific performance and operational standards. Each listing provides detailed specs, functionality data, and replacement compatibility information:

Part Number	Name
10030631	Benzocaine Gel
NDC50486-0550-32	Benzocaine Gel
ZILACTIN-B	Benzocaine Gel

FAQs

Find helpful answers about installation, operation, maintenance, compliance, and troubleshooting.

What is the FSCG of the NSN 6505-01-550-0877?

The FSCG of the NSN 6505-01-550-0877 is 6505

Does the NSN 6505-01-550-0877 have a Schedule B code assigned?

Yes, the Schedule B code is 3004909245

Does NSN 6505-01-550-0877 require demilitarization?

Items subject to the export administration regulations (ear) in parts 730-774 of title 15, code of federal regulations (cfr) (ccli or ear99) and determined by dod to present a low risk when released out of dod control. No demil, mut, or end use certificate is required. May require an export licensefrom doc.

Does NSN 6505-01-550-0877 contain precious materials?

Item does not contain precious metal.

Does NSN 6505-01-550-0877 contain hazardous materials?

Indicates there is no information in the hmirs. The nsn is in a fsc in table ii of fed std 313 and a msds may be required by the user. The requirement for a msds is dependent on a hazard determination of the supplier or the intended end use of item.

When the NSN 6505-01-550-0877 was assigned to the Federal Catalog?

It was assigned 19 years ago, on Mon, Apr 9, 2007